Cancer Flashcards

1
Q

Characteristics of Cancer

A

 An uncontrolled proliferation of cells
 And invasion and spread from site of primary
tumor to other sites in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Tumour

A

Tumours are a dense collection of cells that are created
when the orderly process of cell division goes out of
control and cells divide more rapidly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Benign

A

These are abnormal but they don’t metastasise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Malignant

A

A malignant tumour or a cancer metastasises

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Metastasis

A
  • The main difficulty with cancer cells is that they can
    spread from their original location and populate other
    regions-this is metastasis
  • They usually travel in blood vessels or through the
    lymphatic system
  • Patients usually die as a consequence of metastasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Carcinomas

A

originate from the cells that cover external and internal
body surfaces. Lung, breast, and colon are the most frequent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Sarcomas

A

are cancers arising from cells in the supporting tissues such
as bone, cartilage, fat, connective tissue and muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

lymphomas

A

are cancers that arise in the lymph nodes and tissues of
the immune system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Leukemias

A

are cancers of the immature blood cells that grow in the
bone marrow and are found in large numbers in the bloodstream.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Morphology of Cancer Cells

A
  1. Cancer cells can grow indefinitely in culture
  2. They can pile up on each other
    (no contact inhibition)
  3. They can have multiple nuclei
  4. There can be more than 46 chromosomes
  5. The chromosomes can be abnormal
    The overall morphology can be completely different
    to that of the parent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Grade of a cancer

A

determined using cancer cell morphology - how cells look like under the
microscope (grades I-IV). High grade is associated with lower survival.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Stage

A

measure of the tumour size and metastasis and is based on how
large is the tumor, has it invaded surrounding tissues, and spread to regional
lymph nodes or metastasized to other regions of the body
A patient’s chances for survival are better if cancer is at a lower stage.
Traditional Tumor Classifications- Tumor Staging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Carcinogen

A

a cancer –causing substance or agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Causes of cancer

A

 Cancer ultimately results from the interaction between hereditary
and environmental factors
 Usually not a single factor but a multiple factors with accumulated
effects through life-time
 However, a single factor may be so important that in its absence
a significant number of specific cancers would not occur, for
example smoking
 a single type of cancer can be caused by different
agents
– skin cancer can be caused by UV, ionizing radiation,
polycyclic aromatic hydrocarbons
 many types of cancer are caused by a single agent
– ionising radiation can cause myeloid leukaemia,
osteosarcoma, thyroid cancer, skin cancer or breast
cancer
 complex interactions for a single cancer
– age, UV exposure and DNA repair capacity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Chemicals

A

– e.g. Oils/tars (scrotal cancer in chimney
sweeps; benzo[a]pyrene)
– Fibres (asbestos) and mesothelioma
– Natural products (aflatoxin and liver cancer)
– Heavy metals Chromium, Cadmium etc
– Benzene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Radiation

A

– X-rays, γ-rays, α&β particles
* Cosmic radiation (aircrew)
* Nuclear industry
* Medical (radiotherapy)
– Ultraviolet light
* Sunlight & tanning

17
Q

Viruses

A
  • Viral Infections
    – Human papillomavirus (HPV): cervical cancer
    – Hepatitis B: liver cancer
    – Kaposi’s sarcoma: associated with HIV/AIDS
18
Q

Heredity

A
  • Cancer is not considered an inherited disease
  • However, chances of some people developing cancer can be influenced by
    genetic factors
  • Genetic predisposition
  • BRCA1 & BRCA2 breast cancer genes
  • Ataxia telangiectasia: Hypersensitivity to ionizing radiation, leukaemia &
    lymphoma (mutation in ATM kinase)
  • Familial retinoblastoma (mutations in Rb tumor suppressor)
  • Li-Fraumeni Syndrome: p53 mutations; breast, brain, leukaemia, soft tissue
    sarcomas
19
Q

BRCA1 and BRCA2 genes

A
  • BRCA1 and BRCA2 are tumour suppressor
    genes
  • They are involved in repairing damage to DNA
  • If these genes do not function correctly then
    mutations in DNA occur that can lead to cancer
20
Q

Diet/lifestyle

A
  • Carcinogens in food? e.g. aflatoxin, other chemicals
  • Obesity and cancer: increased risk of breast (in
    older women), endometrial, kidney, colon and
    esophagus cancer
  • Some studies show that large quantities of red and
    preserved meat increases the risk of stomach and
    colorectal cancers, whereas a diet high in fruits and
    vegetables may decrease the risks of these
    cancers. And calorie restriction reduces cancer risk
    of cancer.
21
Q

Hormones

A
  • Androgens linked to prostate cancer
  • Estrogens linked to breast cancer
  • These hormones are considered initiators of cancer
    because they increase proliferative capacity of target
    tissues
22
Q

Cancer Development

A
  • One mutation in a pre-cancerous cell makes it
    more likely that other mutations will persist in
    the genome, e.g. deletion of DNA repair genes
  • Leads to an accumulation of mutations
  • These mutations confer a growth advantage to
    the cancer cells
  • Eventually give rise to Hanahan & Weinberg’s
    ‘Hallmarks of Cancer
23
Q

Oncogenes

A
  • Oncogenes are mutated versions of normal
    genes called proto-oncogenes
  • Products of oncogenes are proteins involved
    in cell growth and division. They function
    normally in the complex network of regulation
    of cell growth. Under abnormal
    circumstances, they may over-stimulate cell
    growth, proliferation or cell survival.
  • A single mutant allele may affect the
    phenotype of a cell therefore dominant
24
Q

Mechanisms of Proto-oncogene
Activation

A
  1. Mutations
    Point mutations/deletions/insertions
  2. Gene amplification
    For reasons not understood, a particular chromosome segment may
    form a very large number of copies. This happens rarely, and in
    most cases the cell does not survive. However, if the repeated
    element includes an oncogene, this may result in abnormal growth.
  3. Chromosomal re-arrangement
    Chromosome rearrangements, such as translocation, can place a
    cellular oncogene under control of the wrong promoter, or lead to
    formation of the gene fusions that code for chimeric proteins
25
Tumour Suppressor Genes
Tumour suppressor (TS) genes encode proteins whose normal function is to inhibit cell proliferation. Cancer cells have lost function of TS genes. Both alleles have to be inactivated to change the phenotype of the cell ….therefore recessive  A tumour suppressor gene that normally acts as a brake must be inactivated.  Full inactivation requires two mutations— both alleles must be turned off  People with inherited predisposition to cancer are born with one mutant allele, and need only one more mutational event for inactivation of the tumour suppressor gene
26
p53
Major functions p53 protein acts as a transcription factor p53 consensus binding site has been identified in promoters of several target genes involved in slowing down cell cycle and causing apoptosis (e.g., p21, Bax) p53 acts as a G1 checkpoint control for DNA damage e.g., following IR, UV irradiation, p53 activity is induced resulting in cell cycle arrest to allow time for repair p53 participates in the initiation of apoptosis
27
E2F Transcription Factor is a Major Controller of the Cell Cycle
* Cell cycle progression, arrest and apoptosis (E2F-1), however other members of the family other effects (E2F1-8); function as heterodimers with DP1 and 2 * Crucial in growth control, specifically G1 to S phase * Target genes - growth stimulation (DHFR, DNA pol α) - growth inhibition (ARF, APAF-1)
28
DNA Repair Mechanisms
* Nucleotide excision repair (NER) Removes larger areas of DNA damaged by chemicals or irradiation * Base excision repair (BER) Targets chemically altered bases * Mismatch repair (MMR) Corrects replication errors that have escaped editing by polymerases
29
Apoptosis
Apoptosis is a highly regulated process of cell death which controls cell numbers and eliminates damaged cells and therefore plays an important role in tumour suppression.
30
Surgery
* If the cancer can be completely removed -then curative * Problem – metastasis * Metastasis – cancer cells split from the primary tumour, travel around the body and form secondary cancers in remote sites * Most cancer deaths arise from secondary cancers * Can not always treat metastasis by surgery
31
Radiotherapy
* Use radiation to kill cancer cells. * Can be external radiation (a beam of x- rays) or internal (radioactive implant). Problems: * Metastasis * Damage to normal tissues.
32
Chemoptherapy
* Drugs come in contact with every cell in the body * Therefore metastasis can be treated * Most drugs are targeted at killing dividing cells Problems: * Normal tissue toxicity. Most healthy cells in an adult are non dividing – exception hair, bone marrow etc. * Resistance * In children most cells dividing Inhibitors of DNA synthesis I. Alkylating agents and platinum based drugs (Chlorambucil, Cyclophosphamide, Cisplatin, Carboplatin) II. Antimetabolites (5-Fluorouracil) * Inhibitors of microtubule formation (Vincristine, Vinblastine, Paclitaxel) * Hormones (glucocorticoids, tamoxifen, antiandrogens) * Organic drugs (Doxorubicin)
33
Inhibitors of Oncogenic Activity
Kinase inhibitors Anti-EGFR (Iressa and Tarceva are drugs that inhibit EGFR kinase activity, Herceptin is a monoclonal antibody) Anti Bcr-Abl [Philadelphia chromosome, (Gleevec is tyrosine- kinase inhibitor)]
34
Types of Immunotherapy
* Monoclonal antibodies * Cancer vaccines * Non-specific immunotherapies and adjuvants * New approaches
35
How to Find New Treatments
* Identify a difference between a cancer cell and normal cells * Design and synthesise a drug to target this difference * Test the drug in model systems * Clinical trials in patients
36
Clinical Trials
* How much drug is ‘safe’? * How much drug is needed to get clinical effect? * How much drug can be given before toxicity (side effects) are seen? * Start with mice, continue with clinical trials. * Future approaches-personalised therapy